SEBI Registered Research Analyst — INH000014182·
Investments in securities are subject to market risks·
Khushal Growwealth Research Private Limited·
Support: support@kgwealth.in·
SEBI Registered Research Analyst — INH000014182·
Investments in securities are subject to market risks·
Khushal Growwealth Research Private Limited·
Support: support@kgwealth.in·
KG WEALTHPvt Ltd · SEBI RA
Pricing

Plans built around the
research you need.

Transparent, GST-inclusive pricing. No upsells, no aggressive renewals — only research-led value.

Plan

Monthly

Start with a single month of full research access.

25,999/mo

Inclusive of GST · Auto-renewal opt-in only

  • Equity + F&O + Commodity research
  • Daily research notes & alerts
  • Entry / target / stop guidance
  • WhatsApp + Email delivery
  • Compliance officer access
Most Picked
Plan

Quarterly

Best balance of commitment and value.

49,999/qtr

Inclusive of GST · Auto-renewal opt-in only

  • Everything in Monthly
  • Priority alerts & adjustments
  • Quarterly thesis review
  • Direct analyst chat support
  • Event-week dedicated playbook
Plan

Half-Yearly

Best value for committed long-term investors.

99,999/6mo

Inclusive of GST · Auto-renewal opt-in only

  • Everything in Quarterly
  • Half-yearly portfolio touch-base
  • Custom research requests (fair-use)
  • Senior analyst escalation channel
  • Priority onboarding
Premium
Premium

Wealth Premium

Bespoke research and a dedicated desk — for HNI clients.

1,75,000/mo

Inclusive of GST · Auto-renewal opt-in only

  • All segments, fully personalised
  • Dedicated senior analyst & RM
  • Live priority alerts & adjustments
  • Monthly 1:1 portfolio review call
  • Custom research on request
  • Direct compliance officer line

Note: All subscriptions require a duly completed consent form and a brief risk-profiling call before activation. Refunds are governed by our Refund Policy. SEBI Reg. INH000014182.

Ready when you are

Let your next decision be research-led.

Pick a plan that fits your style — equity, derivatives, or commodity — and start receiving compliance-vetted, analyst-backed research.